000 a
999 _c16276
_d16276
003 OSt
005 20220208150533.0
008 220208b xxu||||| |||| 00| 0 eng d
040 _aAIKTC-KRRC
_cAIKTC-KRRC
100 _915950
_aPallavi, S. S.
245 _aMicrobial synthesis of silver nanoparticles using streptomyces sp. Pg12 and their characterization, antimicrobial activity and cytotoxicity assessment against human lung (A549) and breast (MCF-7) cancer cell lines
250 _aVol.13(8)
260 _aM P
_bInnovare Academic Sciences Pvt Ltd
_c2021
300 _a94-102p.
520 _aObjective: Synthesis of silver nanoparticles using Streptomyces sp. PG12 and their characterization, antimicrobial activity and cytotoxicity against A549 and MCF-7 cancer cell lines. Methods: The silver nanoparticles were subjected to UV-Vis. spectroscopy, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy with energy-dispersive X-ray spectroscopy (SEM/EDS), high-resolution transmission electron microscopy (HR-TEM), zeta potential, and X-ray diffractometry (XRD) analyses. Further, the antimicrobial potential was determined by using the agar well diffusion method and cytotoxicity was determined with the help of cell viability (MTT) assay and reactive oxygen species (ROS) assay. Results: The initial indication of silver nanoparticles synthesis was noticed by the colour change in the reaction mixture and the absorption maximum at 421 nm in UV-Vis. analysis; whereas, the FTIR analysis displayed the biological functional groups responsible for the capping and stabilization of silver nanoparticles. SEM and TEM micrographs revealed the surface morphology, spherical shape, and smallest particle size as 18.91 nm. The EDS and XRD patterns confirmed the involvement of various elements during the synthesis of silver nanoparticles and the crystalline, face-centered cubic nature, respectively. The silver nanoparticles displayed considerable antimicrobial activity against human pathogens even at low MIC and MBC concentrations and exhibited increased anticancer activity against A549 and MCF-7 cell lines, where the ability of silver nanoparticles to significantly restrict the growth of tumour cells was observed at IC50 values of 69.04μg/ml and 138.30μg/ml, respectively.
650 0 _94639
_aPHARMACEUTICS
700 _915951
_aBhat, Meghashyama Prabhakara
773 0 _x2656-0097
_dBhopal Innovare Academic Sciences Pvt Ltd
_tInternational journal of pharmacy and pharmaceutical science
856 _uhttps://innovareacademics.in/journals/index.php/ijpps/article/view/41876/25210
_yClick here
942 _2ddc
_cAR